trial

Cultivating Well-being in Severe Psychiatric Conditions

NCTId NCT04768959
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 140 (actual)
Sponsored by Universidad Complutense de Madrid
Primary completion 2019-09-25
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
140 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2017-10-25
Primary completion
2019-09-25
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
FelizMente

Sponsors

Universidad Complutense de MadridLead Sponsor

Sites

1 total
Pozuelo de Alarcón, Spain

Facts & assertions

4 sourced
Enrollment
140
Phase
NA
Primary Completion Date
2019-09-25
Status
COMPLETED
relationships
The graph out of here
drug
FelizMente
drug
lead_sponsor
Universidad Complutense de Madrid
company
indication
Wellbeing
indication
Schizophrenia
indication